• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物流产后母血中米非司酮(RU-486)及其代谢物的测定。

Determination of Mifepristone (RU-486) and Its Metabolites in Maternal Blood Sample after Pharmacological Abortion.

机构信息

Department of Forensic Medicine, Wroclaw Medical University, 4 J. Mikulicza-Radeckiego Street, 50345 Wroclaw, Poland.

Institute of Toxicology Research, 45 Kasztanowa Street, 55093 Borowa, Poland.

出版信息

Molecules. 2022 Nov 6;27(21):7605. doi: 10.3390/molecules27217605.

DOI:10.3390/molecules27217605
PMID:36364430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9657224/
Abstract

The aim of the study was the development and validation of the UHPLC-QqQ-MS/MS method for the determination of mifepristone in human blood as well as the identification and quantification of its metabolites after self-induced pharmacological abortion. The metabolic pathway in humans was proposed after examination of an authentic casework. The fast and simple preanalytical procedure was successfully applied (pH9, tert-butyl-methyl ether). The validation parameters of the method were as follows: limit of quantification: 0.5 ng/mL; coefficients of determination: >0.999 (R2), intra- and inter-day accuracy and precision values did not exceed ± 13.2%. The recovery and matrix effect were in the range of 96.3−114.7% and from −3.0 to 14.7%, respectively. Toxicological analysis of the mother’s blood (collected the day after the pregnancy termination) revealed the presence of five compounds: mifepristone (557.4 ng/mL), N-desmethyl-mifepristone (638.7 ng/mL), 22-OH-mifepristone (176.9 ng/mL), N,N-didesmethyl-mifepristone (144.5 ng/mL) and N-desmethyl-hydroxy-mifepristone (qualitatively). To our knowledge, the study presented in this paper is the first report on the concentrations of mifepristone and its metabolites in maternal blood samples after performing a self-induced abortion. The established UHPLC-QqQ-MS/MS method is suitable for forensic toxicological analysis as well as in terms of clinical toxicology in future investigations (examination of pharmacokinetics, bioavailability and metabolism of RU-486).

摘要

本研究旨在开发和验证 UHPLC-QqQ-MS/MS 方法,以测定人血中米非司酮的浓度,并在自我诱导药物流产后鉴定和定量其代谢物。在对一个真实案例进行检查后,提出了人体内的代谢途径。该方法采用了快速简单的预处理程序(pH9,叔丁基-甲基醚)。该方法的验证参数如下:定量下限:0.5ng/mL;决定系数:>0.999(R2),日内和日间准确度和精密度值不超过±13.2%。回收率和基质效应的范围分别为 96.3-114.7%和-3.0-14.7%。对母亲流产后一天采集的血液进行毒理学分析,发现了五种化合物:米非司酮(557.4ng/mL)、N-去甲基米非司酮(638.7ng/mL)、22-羟基米非司酮(176.9ng/mL)、N,N-二去甲基米非司酮(144.5ng/mL)和 N-去甲基羟米非司酮(定性)。据我们所知,本文所报道的研究是首次在自我诱导流产后检测母亲血液中米非司酮及其代谢物浓度的报告。所建立的 UHPLC-QqQ-MS/MS 方法适用于法医毒理学分析以及未来研究中的临床毒理学(检测 RU-486 的药代动力学、生物利用度和代谢)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb6/9657224/6bbfa4f010d1/molecules-27-07605-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb6/9657224/57c2e83cc0c1/molecules-27-07605-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb6/9657224/a62709cc1ee1/molecules-27-07605-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb6/9657224/95d8833f311d/molecules-27-07605-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb6/9657224/7b68cdab001d/molecules-27-07605-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb6/9657224/6bbfa4f010d1/molecules-27-07605-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb6/9657224/57c2e83cc0c1/molecules-27-07605-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb6/9657224/a62709cc1ee1/molecules-27-07605-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb6/9657224/95d8833f311d/molecules-27-07605-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb6/9657224/7b68cdab001d/molecules-27-07605-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb6/9657224/6bbfa4f010d1/molecules-27-07605-g005.jpg

相似文献

1
Determination of Mifepristone (RU-486) and Its Metabolites in Maternal Blood Sample after Pharmacological Abortion.药物流产后母血中米非司酮(RU-486)及其代谢物的测定。
Molecules. 2022 Nov 6;27(21):7605. doi: 10.3390/molecules27217605.
2
Forensic Toxicological Aspects of Misoprostol Use in Pharmacological Abortions.米索前列醇用于药物流产的法医毒理学方面。
Molecules. 2022 Oct 3;27(19):6534. doi: 10.3390/molecules27196534.
3
A randomized clinical trial of mifepristone (RU486) for induction of delayed menses: efficacy and acceptability.米非司酮(RU486)诱导月经推迟的随机临床试验:疗效与可接受性
Contraception. 1992 Jul;46(1):1-10. doi: 10.1016/0010-7824(92)90126-e.
4
An ultra-sensitive UHPLC-QqQ-MS/MS method for determination of 54 benzodiazepines (pharmaceutical drugs, NPS and metabolites) and z-drugs in biological samples.一种用于测定生物样品中54种苯二氮䓬类药物(药品、新型精神活性物质及代谢物)和Z类药物的超灵敏超高效液相色谱-串联四极杆质谱联用方法。
Talanta. 2023 Jan 1;251:123816. doi: 10.1016/j.talanta.2022.123816. Epub 2022 Aug 7.
5
Transplacental passage of mifepristone and its influence on maternal and fetal steroid concentrations in the second trimester of pregnancy.米非司酮的胎盘转运及其对妊娠中期母胎甾体激素浓度的影响。
Hum Reprod. 1991 Mar;6(3):458-62. doi: 10.1093/oxfordjournals.humrep.a137358.
6
Determination of Prostaglandins (Carboprost, Cloprostenol, Dinoprost, Dinoprostone, Misoprostol, Sulprostone) by UHPLC-MS/MS in Toxicological Investigations.超高效液相色谱-串联质谱法测定毒理学研究中的前列腺素(卡前列素、氯前列醇、地诺前列素、地诺前列酮、米索前列醇、舒前列素)
Toxics. 2023 Sep 22;11(10):802. doi: 10.3390/toxics11100802.
7
Abortion: epidemiology, safety, and technique.堕胎:流行病学、安全性与技术
Curr Opin Obstet Gynecol. 1992 Aug;4(4):506-12.
8
A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy.一项关于单独使用吉美前列素、地拉前列素或米非司酮联合吉美前列素终止中期妊娠的研究。
Contraception. 1992 Jul;46(1):11-7. doi: 10.1016/0010-7824(92)90127-f.
9
Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost.米非司酮联合吉美前列素用于早期妊娠流产引产
Acta Obstet Gynecol Scand. 1993 Jan;72(1):39-42. doi: 10.3109/00016349309013347.
10
Mifepristone (RU 486) for induced abortion.米非司酮(RU 486)用于人工流产。
Womens Health Issues. 1993 Fall;3(3):171-5. doi: 10.1016/s1049-3867(05)80252-x.

引用本文的文献

1
Renewed calls for abortion-related research in the post-Roe era.呼吁在罗诉韦德案被推翻后加强与堕胎相关的研究。
Front Public Health. 2023 Dec 18;11:1322299. doi: 10.3389/fpubh.2023.1322299. eCollection 2023.
2
'Abortion tests' developed in Poland spark concern.波兰研发的“堕胎测试”引发担忧。
Nature. 2023 Oct 11. doi: 10.1038/d41586-023-03129-9.

本文引用的文献

1
Forensic Toxicological Aspects of Misoprostol Use in Pharmacological Abortions.米索前列醇用于药物流产的法医毒理学方面。
Molecules. 2022 Oct 3;27(19):6534. doi: 10.3390/molecules27196534.
2
Diclofenac Concentrations in Post-Mortem Specimens-Distribution, Case Reports, and Validated Method (UHPLC-QqQ-MS/MS) for Its Determination.死后标本中双氯芬酸的浓度——分布、病例报告及其测定的验证方法(超高效液相色谱-串联四极杆质谱法)
Toxics. 2022 Jul 26;10(8):421. doi: 10.3390/toxics10080421.
3
Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990-2019.
按收入、地区和堕胎合法状况划分的意外妊娠和堕胎:1990-2019 年综合模型估计。
Lancet Glob Health. 2020 Sep;8(9):e1152-e1161. doi: 10.1016/S2214-109X(20)30315-6. Epub 2020 Jul 22.
4
Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model.全球、区域和次区域不安全人工流产分类,2010-2014 年:贝叶斯层次模型估计。
Lancet. 2017 Nov 25;390(10110):2372-2381. doi: 10.1016/S0140-6736(17)31794-4. Epub 2017 Sep 27.
5
Facility-based treatment for medical complications resulting from unsafe pregnancy termination in the developing world, 2012: a review of evidence from 26 countries.发展中国家因不安全人工流产而导致的医疗并发症的机构治疗,2012 年:来自 26 个国家的证据回顾。
BJOG. 2016 Aug;123(9):1489-98. doi: 10.1111/1471-0528.13552. Epub 2015 Aug 19.
6
Global causes of maternal death: a WHO systematic analysis.全球孕产妇死亡原因:世卫组织系统分析。
Lancet Glob Health. 2014 Jun;2(6):e323-33. doi: 10.1016/S2214-109X(14)70227-X. Epub 2014 May 5.
7
Simultaneous determination of mifepristone and monodemethyl-mifepristone in human plasma by liquid chromatography-tandem mass spectrometry method using levonorgestrel as an internal standard: application to a pharmacokinetic study.采用液相色谱-串联质谱法,以内标左炔诺孕酮同时测定人血浆中的米非司酮和单去甲基米非司酮:在药代动力学研究中的应用
Biomed Chromatogr. 2009 Jan;23(1):71-80. doi: 10.1002/bmc.1086.
8
Development of a high-performance liquid chromatographic method for the determination of mifepristone in human plasma using norethisterone as an internal standard: application to pharmacokinetic study.建立一种以炔诺酮为内标物测定人血浆中米非司酮的高效液相色谱法:应用于药代动力学研究。
Contraception. 2007 Sep;76(3):228-32. doi: 10.1016/j.contraception.2007.04.004. Epub 2007 Aug 1.
9
Simultaneous determination of rivanol and mifepristone in human plasma by a HPLC-UV method with solid-phase extraction.采用固相萃取-高效液相色谱-紫外检测法同时测定人血浆中利凡诺和米非司酮的含量。
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 1;856(1-2):312-7. doi: 10.1016/j.jchromb.2007.06.016. Epub 2007 Jun 26.
10
Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses.液相色谱串联质谱分析中降低基质效应的系统全面策略
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):22-34. doi: 10.1016/j.jchromb.2006.12.030. Epub 2007 Jan 3.